Cheryl E.G. Leyns

Merck, Semoy, Centre-Val de Loire, France 
TREM2, tau, abeta, Alzheimer's disease, Parkinson's disease, LRRK2, GBA, synuclein
"Cheryl Leyns"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Liao F, Li A, Xiong M, et al. (2018) Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation. The Journal of Clinical Investigation
See more...